Contrast in the efficacy of hDAF mouse hearts between ex vivo perfusion and transplantation into primates
- 1 November 2001
- journal article
- research article
- Published by Wiley in Xenotransplantation
- Vol. 8 (4) , 284-291
- https://doi.org/10.1034/j.1399-3089.2001.00132.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Relative roles of hCD46 and hCD55 in the regulation of hyperacute rejectionTransplantation Proceedings, 2000
- COMBINATION OF DECAY-ACCELERATING FACTOR EXPRESSION AND ??1,3-GALACTOSYLTRANSFERASE KNOCKOUT AFFORDS ADDED PROTECTION FROM HUMAN COMPLEMENT-MEDIATED INJURYTransplantation, 1997
- Transgenic expression of a CD46 (membrane cofactor protein) minigene: Studies of xenotransplantation and measles virus infectionEuropean Journal of Immunology, 1997
- Immunobiology of delayed xenograft rejectionTransplantation Proceedings, 1997
- Human CD46 but not CD59 in transgenic mice protects against hyperacute rejection evoked by ex vivo perfusion with human serumTransplantation Proceedings, 1997
- TRANSGENIC PIGS EXPRESSING HUMAN CD59 AND DECAY-ACCELERATING FACTOR PRODUCE AN INTRINSIC BARRIER TO COMPLEMENT-MEDIATED DAMAGE1Transplantation, 1997
- A membrane cofactor protein transgenic mouse model for the study of discordant xenograft rejectionGenes to Cells, 1996
- EXPRESSION OF FUNCTIONAL DECAY-ACCELERATING FACTOR (CD55) IN TRANSGENIC MICE PROTECTS AGAINST HUMAN COMPLEMENT-MEDIATED ATTACK1Transplantation, 1996
- Human CD59 expressed in transgenic mouse hearts inhibits the activation of complementTransplant Immunology, 1995
- PROTECTION OF XENOGENEIC CARDIAC ENDOTHELIUM FROM HUMAN COMPLEMENT BY EXPRESSION OF CD59 OR DAF IN TRANSGENIC MICETransplantation, 1995